12.06.2014 Views

to download - Research Institute for Fragrance Materials

to download - Research Institute for Fragrance Materials

to download - Research Institute for Fragrance Materials

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

EES_4C_EES 10/6/11 12:59 PM Page 1<br />

Reprinted from<br />

Volume 74 , Issue 6 , September 2011<br />

E<br />

E<br />

S<br />

Eco<strong>to</strong>xicology<br />

and<br />

Environmental<br />

Safety<br />

Macrocyclic <strong>Fragrance</strong> <strong>Materials</strong>—A<br />

Screening-Level Environmental<br />

Assessment Using Chemical Categorization<br />

Daniel Salvi<strong>to</strong>, Aurelia Lapczynski, Christen Sachse-Vasquez,<br />

Colin McIn<strong>to</strong>sh, Peter Calow, Helmut Greim, and Beate Escher<br />

<strong>Research</strong> <strong>Institute</strong> <strong>for</strong> <strong>Fragrance</strong> <strong>Materials</strong>, Inc.<br />

www.rifm.org<br />

rifm@rifm.org<br />

http://www.elsevier.com/locate/ecoenv


No responsibility is assumed by Elsevier, its licensors or associates <strong>for</strong> any injury and/or damage <strong>to</strong> persons or property as a matter of products<br />

liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein.<br />

Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.<br />

Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629<br />

Contents lists available at ScienceDirect<br />

Eco<strong>to</strong>xicology and Environmental Safety<br />

journal homepage: www.elsevier.com/locate/ecoenv<br />

Macrocyclic fragrance materials—A screening-level environmental<br />

assessment using chemical categorization<br />

Daniel Salvi<strong>to</strong> a,n , Aurelia Lapczynski a , Christen Sachse-Vasquez b , Colin McIn<strong>to</strong>sh c , Peter Calow d ,<br />

Helmut Greim e , Beate Escher f<br />

a <strong>Research</strong> <strong>Institute</strong> <strong>for</strong> <strong>Fragrance</strong> <strong>Materials</strong>, 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA<br />

b Takasago International Corporation, Rockleigh, NJ, USA<br />

c Firmenich, Inc. Prince<strong>to</strong>n, NJ, USA<br />

d Roskilde University, Department of Environmental, Social & Spatial Change, Roskilde, Denmark<br />

e Technical University of Munich, <strong>Institute</strong> <strong>for</strong> Toxicology & Environmental Hygiene, Freising-Weihenstephan, Germany<br />

f University of Queensland, National <strong>Research</strong> Centre <strong>for</strong> Environment Toxicology (EnTox), Coopers Plains, Australia<br />

article info<br />

Article his<strong>to</strong>ry:<br />

Received 15 December 2010<br />

Received in revised <strong>for</strong>m<br />

4 May 2011<br />

Accepted 5 May 2011<br />

Available online 12 June 2011<br />

Keywords:<br />

Risk assessment<br />

Chemical categorization<br />

<strong>Fragrance</strong> ingredients<br />

abstract<br />

A screening-level aquatic environmental risk assessment <strong>for</strong> macrocyclic fragrance materials using a<br />

‘‘group approach’’ is presented using data <strong>for</strong> 30 macrocyclic fragrance ingredients. In this group<br />

approach, conservative estimates of environmental exposure and eco<strong>to</strong>xicological effects thresholds <strong>for</strong><br />

compounds within two subgroups (15 macrocyclic ke<strong>to</strong>nes and 15 macrocyclic lac<strong>to</strong>nes/lactides) were<br />

used <strong>to</strong> estimate the aquatic ecological risk potential <strong>for</strong> these subgroups. It is reasonable <strong>to</strong> separate<br />

these fragrance materials in<strong>to</strong> the two subgroups based on the likely metabolic pathway required <strong>for</strong><br />

biodegradation and on expected different eco<strong>to</strong>xicological modes of action. The current volumes of use<br />

<strong>for</strong> the macrocyclic ke<strong>to</strong>nes in both Europe and North America ranges from o1 (low kg quantities) <strong>to</strong> no<br />

greater than 50 metric <strong>to</strong>nnes in either region and <strong>for</strong> macrocyclic lac<strong>to</strong>nes/lactides the volume of use<br />

range <strong>for</strong> both regions is o1 <strong>to</strong> no greater than 1000 metric <strong>to</strong>nnes in any one region. Based on these<br />

regional <strong>to</strong>nnages, biodegradability of these two subgroups of materials, and minimal in stream dilution<br />

(3:1), the conservatively predicted exposure concentrations <strong>for</strong> macrocyclic ke<strong>to</strong>nes would range from<br />

o0.01 <strong>to</strong> 0.05 mg/L in Europe and from o0.01 <strong>to</strong> 0.03 mg/L in North America. For macrocyclic lac<strong>to</strong>nes/<br />

lactides, the concentration within the mixing zone would range from o0.01 <strong>to</strong> 0.7 mg/L in Europe and<br />

from o0.01 <strong>to</strong> 1.0 mg/L in North America. The PNECs derived <strong>for</strong> the macrocyclic ke<strong>to</strong>nes is 0.22 mg/L<br />

and <strong>for</strong> macrocyclic lac<strong>to</strong>nes/lactides is 2.7 mg/L. The results of this screening-level aquatic ecological<br />

risk assessment indicate that at their current <strong>to</strong>nnage, often referred <strong>to</strong> as volumes of use, macrocyclic<br />

fragrance materials in Europe and North America, pose a negligible risk <strong>to</strong> aquatic biota; with no PEC/<br />

PNEC ratio exceeding 1 <strong>for</strong> any material in any subgroup.<br />

& 2011 Elsevier Inc. All rights reserved.<br />

1. Introduction<br />

The <strong>Research</strong> <strong>Institute</strong> <strong>for</strong> <strong>Fragrance</strong> <strong>Materials</strong> (RIFM) ‘‘Framework<br />

<strong>for</strong> prioritizing fragrance materials <strong>for</strong> aquatic risk assessment’’<br />

(termed ‘‘Environmental Framework’’ hereafter) was developed <strong>to</strong><br />

screen a large database of organic compounds used as fragrance<br />

ingredients <strong>to</strong> assess their potential environmental risk and set<br />

priorities <strong>for</strong> further risk assessment, as necessary (Salvi<strong>to</strong> et al.,<br />

2002). RIFM has been using a group or chemical categories approach<br />

based on structure–activity relationships <strong>for</strong> the assessment of<br />

human health safety (Bickers et al., 2003). Presented here is the first<br />

n Corresponding author.<br />

E-mail address: dsalvi<strong>to</strong>@rifm.org (D. Salvi<strong>to</strong>).<br />

0147-6513/$ - see front matter & 2011 Elsevier Inc. All rights reserved.<br />

doi:10.1016/j.ecoenv.2011.05.002<br />

application of this group approach <strong>for</strong> the aquatic risk assessment of<br />

structurally related groups of fragrance ingredients using the example<br />

of macrocyclic fragrance ingredients. Macrocyclic fragrance materials<br />

are important fragrance ingredients and are widely used in cosmetics,<br />

detergents, fabric softeners, cleaning products and other household<br />

products.Thisapproachisbasedonthehypothesisthatifchemicals<br />

are structurally related, they behave similarly in the aquatic environment.<br />

In the group approach, available environmental fate and effects<br />

values <strong>for</strong> individual compounds within the group are used <strong>to</strong><br />

conservatively estimate the potential <strong>for</strong> aquatic ecological risks <strong>for</strong><br />

the entire structurally related group. The fragrance materials in the<br />

macrocyclic ke<strong>to</strong>ne group and the macrocyclic lac<strong>to</strong>ne and lactide<br />

group have been reviewed in separate human health group summaries<br />

(Belsi<strong>to</strong> et al., in press a, b). These group summaries contain<br />

references <strong>to</strong> the <strong>Fragrance</strong> Material Reviews that provide the human<br />

health data <strong>for</strong> each of the individual materials in the group.


1620<br />

D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629<br />

1.1. Principles of chemical categorization<br />

Chemical categorization, also referred <strong>to</strong> as ‘‘chemical grouping’’,<br />

is a method of identifying analogs <strong>for</strong> chemicals of interest<br />

and enabling the extrapolation of a specific endpoint(s) of datapoor<br />

chemicals from data rich chemicals. Analogs can be readacross<br />

one chemical <strong>to</strong> one chemical, one <strong>to</strong> many, or many <strong>to</strong><br />

many. The OECD has established guidance on the <strong>for</strong>mation of<br />

categories and guidance has also been prepared in preparation <strong>for</strong><br />

REACH by a REACH Implementation Project (OECD, 2005).<br />

1.2. General guidelines<br />

The group approach as applied here followed the guidance<br />

provided by the OECD (OECD, 2005) <strong>for</strong> the <strong>for</strong>mation of chemical<br />

categories. This guidance could be applied <strong>to</strong> both human health<br />

and environmental endpoints. The principles are:<br />

1. Identify chemical category and assign its members.<br />

2. Gather published and unpublished data <strong>for</strong> each category<br />

member.<br />

3. Evaluate available data <strong>for</strong> adequacy in assessing the domain<br />

hypothesis.<br />

4. Construct a matrix of data availability.<br />

5. Per<strong>for</strong>m an internal assessment of the category.<br />

6. Prepare a category test plan.<br />

7. Conduct the necessary testing.<br />

8. Per<strong>for</strong>m an external assessment of the category and fill data gaps.<br />

The key steps <strong>for</strong> establishing a hypothesis and determining<br />

the validity of the hypothesis are steps 1 and 5; supported by the<br />

data gathering and review steps (2 through 4). Step 1 identifies<br />

the potential domain of the category and establishes the hypothesis<br />

built upon said domain. In a general sense a group of organic<br />

chemicals containing similar functional groups and covering a<br />

specified physical–chemical property range, potentially linked<br />

metabolically, should have endpoints that are predictive based<br />

on the findings of other members within the category.<br />

The purpose of Step 5 is <strong>to</strong> test the hypothesis <strong>for</strong>mulated in<br />

Step 1; i.e. trying <strong>to</strong> refute its premise that the group selected is a<br />

reasonable one <strong>for</strong> read-across. This is done using the existing<br />

in<strong>for</strong>mation and, assessing in parallel persistence (P), bioaccumulation<br />

(B) and <strong>to</strong>xicity (T) criteria. This part of the analysis will<br />

involve a more careful consideration of structure, QSAR and<br />

metabolic pathways than in Step 1. For example, the endpoints<br />

should support the metabolic pathway hypothesis and/or fit a<br />

well-validated QSAR. The possible outcomes of Step 5 are:<br />

Reject the entire category (should occur rarely).<br />

Reject some members based on sound scientific reasoning—<br />

poor fit with remaining members (expected outcome).<br />

Develop candidate subcategories ( note that the outcome here may<br />

be hierarchal; e.g. a ‘‘P’’ group with 2 different ‘‘BT’’ subgroups).<br />

Subcategory size should be the largest possible group of<br />

chemicals that shows common features (i.e., supports the domain<br />

hypothesis). However, the category itself may be the best fit <strong>for</strong><br />

all endpoints (i.e., no need <strong>for</strong> subcategorization).<br />

At this point there is likely <strong>to</strong> be a need <strong>for</strong> the collection of<br />

more data (Steps 6–8) <strong>for</strong> at least two purposes. To further test<br />

the hypothesis that the category is a sound one and <strong>to</strong> fill<br />

important data gaps.<br />

The following points have <strong>to</strong> be considered during the process:<br />

Categorization and its associated hypothesis testing is a weight<br />

of evidence approach. There are likely <strong>to</strong> be outliers that should<br />

fit the category but do not. To the extent possible, these<br />

outliers should be explained; e.g., a, b unsaturation with<br />

respect <strong>to</strong> carbonyl groups present is a different category that<br />

is not part of the general group of ke<strong>to</strong>nes.<br />

Categorization is an approach in which both the favorable and<br />

unfavorable aspects of available data are applied equally.<br />

The use of chemical categories does not preclude minimal<br />

testing strategies (i.e., minimally, physical–chemical properties<br />

have <strong>to</strong> be measured or estimated and ready biodegradation<br />

studies will need <strong>to</strong> be per<strong>for</strong>med).<br />

Subcategories <strong>for</strong> different endpoints may not match between<br />

endpoints relevant <strong>for</strong> human health and environmental endpoints<br />

(or even within); e.g., a skin sensitization subcategory<br />

may not contain all the same members as a persistence<br />

subcategory.<br />

Consideration of consistency between categories is important<br />

as well. There will be chemicals that will reside in more than<br />

one category. The development of the domain parameters and<br />

the category hypothesis should be applicable <strong>for</strong> the chemical<br />

in both (or more) categories. Furthermore, the conclusions <strong>for</strong><br />

the appropriate subcategories, in this case where a chemical<br />

would reside in two distinct groups, should be consistent (e.g.,<br />

the chemical cannot be bioaccumulative in one subcategory<br />

and not bioaccumulative in another).<br />

1.3. Specific guidelines <strong>for</strong> endpoint assessment in categorization<br />

While the principles outlined above provide guidance <strong>for</strong> the<br />

building and assessment of chemical categories in a broad sense,<br />

below are additional guidance <strong>for</strong> evaluating specific endpoints<br />

<strong>for</strong> environmental exposure (persistence and bioaccumulation<br />

data) and aquatic effects.<br />

1.3.1. Persistence<br />

If no experimental data are available the following computational<br />

models can serve as assessment <strong>to</strong>ols:<br />

(a) CATABOL—<strong>for</strong> commonality of metabolic pathways;<br />

(b) METEOR—<strong>for</strong> mammalian metabolism; may be useful <strong>for</strong> P<br />

assessment and <strong>for</strong> fish metabolism;<br />

(c) University of Minnesota Biocatalysis/Biodegradation<br />

Database—<strong>for</strong> degradation reaction pathways.<br />

The following questions need <strong>to</strong> be addressed:<br />

1. Structural assessment: Does the same path exist <strong>for</strong> the<br />

chemicals in the groups <strong>for</strong> initial primary degradation (same<br />

sites of attack)?<br />

2. Are there breaks in the available dataset between readily<br />

biodegradable materials, inherently biodegradable materials,<br />

and non-biodegradable materials that are structurally defined?<br />

3. Structural assessment: Is the pathway <strong>for</strong> biodegradation likely<br />

<strong>to</strong> go <strong>to</strong> completion (mineralization) or are there structural<br />

biophobes that are likely <strong>to</strong> inhibit this process?<br />

4. Do potential metabolites (i.e., breakdown products), of the<br />

chemicals that do not completely metabolize have B or T<br />

properties?<br />

5. What is the expectation of per<strong>for</strong>mance in a ready test (should<br />

be able <strong>to</strong> predict % biodegradation)?<br />

6. If no ready biodegradation is predicted:<br />

(a) Is the material <strong>to</strong>xic under test conditions?<br />

(b) Do organisms have difficulty growing on the chemical <strong>to</strong><br />

permit primary degradation (i.e., co-metabolism)?<br />

(c) Is the material bioavailable?<br />

(d) What is expected in aerobic versus anaerobic tests?


D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629 1621<br />

1.3.2. Bioaccumulation<br />

In a first step, the materials are grouped in classes with known<br />

metabolic activity versus non- or poorly metabolized materials.<br />

For non (poorly)-metabolizable chemicals separations between<br />

non-B/B/vB is based on the hydrophobicity indica<strong>to</strong>r octanol–<br />

water partition coefficient K OW ;<br />

For categories with more than one metabolic pathway, separate<br />

by pathway.<br />

1.3.3. Eco<strong>to</strong>xicity<br />

The classes are separated via mode of action (MOA) classification.<br />

For fragrance materials this separation is largely between<br />

narcosis (both Type I and II) and reactive <strong>to</strong>xicants (e.g., aldehydes).<br />

These mode-of-action classifications were originally<br />

proposed by Verhaar et al. (1992) and have had wide application<br />

in eco<strong>to</strong>xicology. MOA I and II (nonpolar and polar narcosis)<br />

chemicals can more than likely be grouped <strong>to</strong>gether as they have<br />

a common underlying mechanism (Vaes et al., 1998). The difference<br />

is not very significant. ECETOC developed a more robust<br />

method <strong>for</strong> determining MOA (Thomas et al., 2008) beyond the<br />

use of the structural alerts of Verhaar et al. (1992).<br />

This weight of evidence approach, in whole or in part, may<br />

prove useful in categorizing <strong>for</strong> eco<strong>to</strong>xic endpoints.<br />

2. <strong>Materials</strong> and methods<br />

identified in this study are a complete list of macrocyclic fragrance materials, as of<br />

this publication, used in commerce and found in the RIFM Database. The process<br />

described above <strong>for</strong> defining and assessing chemical categories was adhered <strong>to</strong>.<br />

Both of these classes are represented by a large carbon ring (typically 14–17<br />

carbons, Fig. 1). Unsaturation may also be present on the carbon ring. From the<br />

domain assessment that follows and a review of the available data, the presence or<br />

absence of unsaturation in the ring does not appear <strong>to</strong> necessitate further<br />

differentiation of these subgroups (i.e., there is no apparent effect on biodegradation<br />

or <strong>to</strong>xicity <strong>for</strong> these chemicals). The macrocyclic ke<strong>to</strong>nes contain only a single<br />

carbonyl functional group on the ring. The macrocyclic lac<strong>to</strong>nes/lactides contains<br />

one or two cyclic ester functional groups and, in the case of the lac<strong>to</strong>nes may also<br />

contain an additional ring oxygen or carbonyl group. Thirty different macrocyclic<br />

compounds were included in this group assessment, 15 lac<strong>to</strong>nes/lactides and 15<br />

ke<strong>to</strong>nes. Their physical–chemical properties are presented in Table 1. Measured<br />

data are provided where available. When measured values were not available,<br />

physical–chemical property estimates were calculated using the USEPA’s EPI Suite<br />

models (version 4.0).<br />

2.1.2. Microbial metabolism<br />

2.1.2.1. Gather published and unpublished data <strong>for</strong> each category member; evaluate<br />

available data <strong>for</strong> adequacy; construct a matrix of data availability. In addition <strong>to</strong> the<br />

structural differences between the two chemical classes, the macrocyclic ke<strong>to</strong>nes<br />

would have <strong>to</strong> undergo oxidation <strong>to</strong> a lac<strong>to</strong>ne during biodegradation and then<br />

further degrade via ester hydrolysis. The materials in the lac<strong>to</strong>ne/lactide subgroup<br />

would, there<strong>for</strong>e, degrade directly via ester hydrolysis. This microbial pathway<br />

was identified using the University of Minnesota Biocatalysis/Biodegradation<br />

Database (Gao et al., 2010) and shows, <strong>for</strong> cyclohexanone, Baeyer–Villiger oxidation<br />

of a cyclic ke<strong>to</strong>ne <strong>to</strong> a cyclic lac<strong>to</strong>ne (neutral under aerobic conditions)<br />

followed by the lac<strong>to</strong>ne <strong>for</strong>ming the hydroxy carboxylate (likely under aerobic<br />

conditions). A representative reaction pathway is shown in Fig. 2.<br />

2.1. Domain definition: macrocyclic fragrance ingredients<br />

2.1.1. Structural similarity and physical–chemical properties (identify chemical<br />

category and assign its members)<br />

These macrocyclic fragrance materials are important fragrance ingredients<br />

and are widely used in cosmetics, detergents, fabric softeners, cleaning products<br />

and other household products. The groups of macrocyclic fragrance ingredients<br />

identified <strong>for</strong> this study consist of two structural classes (i.e., subcategories),<br />

macrocyclic ke<strong>to</strong>nes and macrocyclic lac<strong>to</strong>nes/lactides. The materials specifically<br />

2.1.2.2. Per<strong>for</strong>m an internal assessment of the category. The two principally different<br />

pathways are supported by the difference in biodegradation predicted by BIOWIN<br />

<strong>for</strong> the two classes (i.e., predict ‘‘not readily biodegradable’’ <strong>for</strong> the ke<strong>to</strong>nes and<br />

‘‘readily biodegradable’’ <strong>for</strong> the lac<strong>to</strong>nes/lactides). This difference in prediction by<br />

the BIOWIN model is likely due <strong>to</strong> the necessity of an initial oxidation step <strong>for</strong> the<br />

ke<strong>to</strong>nes as noted above. Standardized experimental studies of biodegradation may<br />

not necessarily provide the data needed <strong>to</strong> demonstrate this difference. Thus, based<br />

on a weight of evidence approach, the biodegradation data <strong>for</strong> both groups of<br />

materials indicates that these compounds are readily biodegradable. However, the<br />

O<br />

O<br />

O<br />

Fig. 1. Domain definition.


1622<br />

D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629<br />

Table 1<br />

Physical chemical properties.<br />

CAS# Name 2008 Vol Global 2008 Vol EU 2008 Vol NA MW Formula K OW Solubility<br />

(aq) (mg/L)<br />

Vapor pressure<br />

(mm Hg 25 1C)<br />

Ke<strong>to</strong>nes<br />

542-46-1 9-Cycloheptadecen-1-one o1 o1 o1 250.43 C 17 H 30 O 6.31 0.096 0.00034<br />

2550-52-9 Cyclohexadecanone 1–10 1–10 1–10 238.41 C 16 H 30 O 6.04 0.19 0.00026<br />

2550-59-6 7-Cyclohexadecen-1-one o1 NR o1 236.4 C 16 H 28 O 5.82 0.30 0.00024<br />

37609-25-9 5-Cyclohexadecen-1-one 10–100 10–100 1–10 236.99 C16H28O 5.82 0.30 0.00024<br />

3100-36-5 Cyclohexadec-8-en-1-one mixture of cis and trans isomer 10–100 10–100 1–10 236.99<br />

502-72-7 Cyclopentadecanone 10–100 10–100 10–100 224.39 C 15 H 28 O 5.55 0.60 0.00042<br />

63314-79-4 5-Cyclopentadecen-1-one, 3-methyl- 1–10 NR 1–10 236.4 C 16 H 28 O 6.57 (m) 0.100 (m) 0.0003 (m)<br />

35720-57-1 4-Cyclopentadecen-1-one 1–10 1–10 NR 222.37 C 15 H 26 O 5.33 0.94 0.00057<br />

14595-54-1 4-Cyclopentadecen-1-one, (Z)- 1–10 o1 1–10<br />

3603-99-4 Cyclotetradecan-1-one 0 0 0 210.61 C 14 H 26 O 5.05 1.87 0.0016<br />

259854-70-1 5-Cyclotetradecen-1-one, 3-methyl-,(5E)- 1–10 o1 o1 222.37 C15H26O 5.6 (m) 1.08 0.0011<br />

259854-71-2 5-Cyclotetradecen-1-one, 3-methyl-, (5Z)- NR NR NR<br />

541-91-3 3-Methyl-1-cyclopentadecanone 1–10 1–10 o1 238.42 C 16 H 30 O 5.96 0.22 0.00047<br />

82356-51-2 3-Methylcyclopentadecenone 10–100 10–100 10–100 C 16 H 28 O 44.88 (m) 0.899 (m) a 0.0003 (m)<br />

61415-11-0 3-Methylcyclotridecan-1-one NR NR NR 210.61 C 14 H 26 O 4.98 2.16 0.0021<br />

Lac<strong>to</strong>nes/lactides<br />

105-95-3 Ethylene brassylate 41000 100–1000 100–1000 270.37 C 15 H 26 O 4 4.7 (m) 1.72 4.4e 007<br />

54982-83-1 Ethylene dodecanedioate 100–1000 100–1000 100–1000 256.35 C14H24O4 3.65 (m) 75 (m) 0.00021 (m)<br />

109-29-5 Hexadecanolide 10–100 10–100 10–100 254.42 C16H30O2 6.65 0.047 2.5e 005<br />

7779-50-2 o-6-Hexadecenlac<strong>to</strong>ne o1 o1 o1 252.4 C 16 H 28 O 2 5.51 (m); 6.7 (m) –out<br />

of method range<br />

0.59 2.2e 005<br />

123-69-3 16-Hydroxy-7-hexadecenoic acid lac<strong>to</strong>ne o1 NR o1 252.39 C 16 H 28 O 2<br />

28645-51-4 Oxacycloheptadec-10-ene-2-one 10–100 10–100 10–100 252.39 C 16 H 28 O 2<br />

36508-31-3 Oxacycloheptadec-11-en-2-one o1 o1 o1 252.39 C 16 H 28 O 2<br />

38223-29-9 Oxacyclohexadecane-2,13-dione o1 o1 o1 254.37 C15H26O3 4.1 80 (m) 0.0006 (m)<br />

34902-57-3 Oxacyclohexadecen-2-one 100–1000 100–1000 100–1000 238.37 C15H26O2 46.2 (m); 43.94 (m);<br />

4.88 calc<br />

0. 964 (m) 0.0012 (m)<br />

111879-80-2 E- and Z-Oxacyclohexadec-12(þ13)-en-2-one 10–100 10–100 10–100<br />

329925-33-9 Oxacyclopentadec-10-en-2-one, 13-methyl- 1–10 1–10 1–10 238.37 C 15 H 26 O 2 2 isomers 5.8; 6.0 (m) 2.15 7.0 e 5<br />

1725-01-5 10-Oxahexadecanolide 1–10 o1 1–10 256.39 C 15 H 28 O 3 4.9 1.43 1.6e 005<br />

3391-83-1 11-Oxahexadecanolide 1–10 1–10 o1 256.39 C 15 H 28 O 3 4.9 1.43 1.6e 005<br />

6707-60-4 12-Oxahexadecanolide 1–10 1–10 o1 256.39 C15H28O3 4.9 1.43 1.6e 005<br />

106-02-5 o-Pentadecalac<strong>to</strong>ne 100–1000 100–1000 100–1000 240.39 C15H28O2 6.15 0.15 5.17e 005<br />

Properties calculated using EPISUITE 4.0 unless noted as measured: m.<br />

Volume range is in metric <strong>to</strong>nes.<br />

As several of these materials are structural isomers, the physical–chemical properties <strong>for</strong> isomers are grouped and only one value is reported.<br />

NR: None reported.<br />

a pH of 6.3 and 20 1C; another study at pH of 9.15 and 20 1C reports a solubility of o0.07 mg/L.


D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629 1623<br />

O<br />

O<br />

O<br />

OH<br />

O-<br />

O<br />

Fig. 2. Representative reaction pathway <strong>for</strong> microbial metabolism of macrocyclic ke<strong>to</strong>nes and lac<strong>to</strong>nes.<br />

known difference in metabolism does support the distinction between the two<br />

subclasses (Table 2).<br />

2.1.3. Eco<strong>to</strong>xicological mode of action<br />

2.1.3.1. Gather published and unpublished data <strong>for</strong> each category member, evaluate<br />

available data <strong>for</strong> adequacy, construct a matrix of data availability. The aquatic<br />

<strong>to</strong>xicity data is summarized in Table 3.<br />

Note: References noted in Tables 2 and 3 represent a significant number of<br />

unpublished studies from the RIFM Database. The complete citations <strong>for</strong> these<br />

studies can be found in the Supplemental In<strong>for</strong>mation provided <strong>for</strong> this paper.<br />

2.1.3.2. Per<strong>for</strong>m an internal assessment of the category. According <strong>to</strong> Verhaar et al.’s<br />

(1992) rules <strong>for</strong> identifying eco<strong>to</strong>xicological mode of action <strong>for</strong> organic compounds,<br />

the ke<strong>to</strong>nes would likely act as non-polar narcotics (Type I) and the lac<strong>to</strong>nes/lactides<br />

as polar narcotics (Type II). As noted earlier, as there is little <strong>to</strong><br />

differentiate between these two modes of action, the measured aquatic <strong>to</strong>xicity<br />

varies little between the two subcategories. It can be noted, in support of this<br />

distinction, that the USEPA’s QSAR model ECOSAR differentiates between the two<br />

classes of compounds as well. ECOSAR applies the neutral organic QSAR <strong>to</strong> the<br />

ke<strong>to</strong>nes and the ester QSAR <strong>to</strong> the lac<strong>to</strong>nes/lactides. Furthermore, comparison<br />

between the output of this QSAR and measured <strong>to</strong>xicity values is not necessarily<br />

confirma<strong>to</strong>ry of correct classification of a chemical category. These QSARs both<br />

under and over predict <strong>to</strong>xicity compared with experimental results.<br />

2.1.4. Conclusion on chemical categories<br />

As noted in Section 2.1.2, the measured experimental data <strong>for</strong> these two<br />

subgroups, are likely not sensitive enough <strong>to</strong> differentiate between the additional<br />

oxidation step needed <strong>for</strong> biodegradation or <strong>for</strong> differences between Type I and<br />

Type II narcosis in aquatic <strong>to</strong>xicity. However, following the Guidelines <strong>for</strong><br />

categorization, the structural differences, microbial pathway <strong>for</strong> degradation,<br />

and eco<strong>to</strong>xicological modes of action support the hypothesis that the macrocyclic<br />

fragrance materials are separable in<strong>to</strong> two subcategories: ke<strong>to</strong>nes and lac<strong>to</strong>ines/<br />

lactides (Fig. 3). As this is an exercise in hypothesis testing, the data, in and of<br />

themselves, do not refute this hypothesis.<br />

2.2. Screening level risk assessment <strong>for</strong> the aquatic compartment<br />

2.2.1. Problem <strong>for</strong>mulation<br />

A screening-level risk assessment was per<strong>for</strong>med using the RIFM Environmental<br />

Framework (Salvi<strong>to</strong> et al., 2002). This framework includes problem <strong>for</strong>mulation,<br />

evaluation of exposure (via a conservative predicted environmental concentration<br />

based on each individual material’s continental <strong>to</strong>nnage) and eco<strong>to</strong>xicological effect<br />

(via a predicted no effect concentration based on the lowest aquatic <strong>to</strong>xicity<br />

endpoint measured <strong>for</strong> any one material within a subgroup, but applied <strong>to</strong> the<br />

whole subgroup) and risk characterization. The assessment was per<strong>for</strong>med <strong>for</strong> each<br />

group using data from all compounds in the group.<br />

2.2.2. Analysis—characterization of exposure: PEC<br />

The primary pathway by which fragrance materials can enter the environment<br />

during and after consumer use is as wastewater washed down drains (Salvi<strong>to</strong><br />

et al., 2002). A portion of the fragrance materials may volatilize <strong>to</strong> the atmosphere.<br />

The amount depends upon the type of consumer product the fragrance material is<br />

used in and the volatility of the fragrance compound. Another fraction will leave<br />

the household in the wastewater. Most wastewater is discharged <strong>to</strong> sewers that<br />

connect <strong>to</strong> wastewater treatment plants (WWTPs), and thus considering the <strong>to</strong>tal<br />

volume of use of the fragrance materials discharged <strong>to</strong> the wastewater is an<br />

appropriately conservative approach <strong>for</strong> a screening level risk assessment as<br />

described in the Framework (Salvi<strong>to</strong> et al., 2002) and is also consistent with the<br />

ERA guidelines <strong>for</strong> pharmaceuticals (EMEA, 2006).<br />

A typical WWTP includes primary treatment <strong>to</strong> remove solids and secondary<br />

treatment <strong>to</strong> remove dissolved and suspended organic matter. The most common<br />

type of secondary treatment is activated sludge. Removal of fragrance materials<br />

can involve sorption <strong>to</strong> sewage solids in primary and secondary treatment,<br />

biodegradation or biotrans<strong>for</strong>mation mainly during secondary treatment, and<br />

removal by clarification in the final clarifier be<strong>for</strong>e discharge <strong>to</strong> the aquatic<br />

environment. During conveyance in the sewer and treatment, some material can<br />

volatilize <strong>to</strong> the atmosphere. In addition, materials can be biodegraded, biotrans<strong>for</strong>med,<br />

and sorbed <strong>to</strong> the sludge within the sewer. <strong>Materials</strong> removed by sorption<br />

<strong>to</strong> the sludge in the WWTP may be incinerated, landfilled, or amended <strong>to</strong> soil.<br />

Material not removed in the WWTP is discharged <strong>to</strong> surface waters, where<br />

biotrans<strong>for</strong>mation and biodegradation can continue. In the surface waters,<br />

materials may sorb <strong>to</strong> suspended solids and be transferred <strong>to</strong> the sediments.<br />

Exposure is expressed as a PEC in the water column of the mixing zone, where<br />

WWTP effluent is diluted with surface water (e.g., stream or river). This<br />

concentration is determined by fragrance usage volume, removal during WWTP<br />

treatment, and dilution in the mixing zone (Salvi<strong>to</strong> et al., 2002). This approach<br />

makes the following assumptions: the entire fragrance usage volume in a region is<br />

discharged via sewers <strong>to</strong> WWTPs; usage is evenly distributed across the population<br />

of a region; no losses occur during consumer use or conveyance in the sewer<br />

as a result of volatilization or other processes; no losses occur as a result of<br />

biodegradation, biotrans<strong>for</strong>mation, or abiotic chemical processes; and effluents<br />

are minimally diluted (3:1) in the mixing zone. As noted in Salvi<strong>to</strong> et al. (2002) a<br />

3:1 dilution is a conservative dilution estimate especially relative <strong>to</strong> the 10:1<br />

dilution recommended in the technical guidance in Europe <strong>for</strong> local-scale<br />

exposure calculations (ECHA, 2008a). The assumptions used in estimating operational<br />

aspects of wastewater treatment are that wastewater undergoes primary<br />

and secondary (activated sludge) treatment, removal during sewage treatment<br />

occurs only as a result of sorption, removal of solids during primary treatment is<br />

only 50% (many plants exhibit better efficiency), the level of suspended solids in<br />

the aeration vessel of the activated sludge system is 2500 mg/L (<strong>for</strong> many plants<br />

this value is closer <strong>to</strong> 3500 mg/L), and the level of solids in final effluent is 20 mg/L<br />

(many plants have much lower solids levels in their effluents). This assessment<br />

depends on three input variables: regional usage volume (metric <strong>to</strong>ns/year),<br />

octanol–water partitioning coefficient (K OW ), and molecular weight. The model<br />

parameters and the conservative nature of this approach have been discussed<br />

elsewhere (Salvi<strong>to</strong> et al., 2002). Macrocyclic fragrance materials have estimated<br />

log K OW values ranging from about 4.2 <strong>to</strong> about 6.7. Molecular weights generally<br />

are around 250 g/mol (Table 1). Population differences, per capita water usage,<br />

and influent solid levels are the variants between scenarios <strong>for</strong> European and<br />

North American screening level exposure assessments (Salvi<strong>to</strong> et al., 2002).<br />

2.2.2.1. Calculation of the PEC. The PECs <strong>for</strong> all materials were estimated individually<br />

using the model described in the RIFM Environmental Framework (Salvi<strong>to</strong> et al.,<br />

2002) <strong>for</strong> the European and North American scenarios. For macrocyclic fragrance<br />

materials, the PEC was estimated based on the reported volume of use (IFRA, 2008) in<br />

Europe and North America, the individual material’s log K OW value, and a 3:1 dilution<br />

ratio <strong>to</strong> estimate exposure in the receiving stream. As the screening level assessment<br />

outlined in Salvi<strong>to</strong> et al. (2002) is able <strong>to</strong> incorporate measured biodegradation data<br />

when available, as is the case <strong>for</strong> both macrocyclic fragrance ingredient subgroups,<br />

this rate (1/h) was included in the analysis (Salvi<strong>to</strong> et al., 2002).<br />

2.2.3. Analysis—characterization of ecological effects: PNEC<br />

The potential <strong>to</strong>xic effects of a fragrance material in the aquatic environment<br />

were expressed in terms of a PNEC. All measured acute and chronic <strong>to</strong>xicity data<br />

available <strong>for</strong> each subgroup of compounds were evaluated and the lowest chronic<br />

no observed effect concentration (NOEC) <strong>for</strong> the subgroup was identified, based on<br />

measured concentrations. As data are not available <strong>for</strong> each compound in the<br />

particular subgroup, this NOEC was applied <strong>to</strong> all compounds within the subgroup<br />

<strong>to</strong> calculate risk quotients. This is consistent with using a ‘‘group approach’’. All of<br />

the <strong>to</strong>xicity tests were per<strong>for</strong>med using Organization <strong>for</strong> Economic Cooperation<br />

and Development (OECD) methods (OECD, 2006a) or similar methodologies and<br />

are noted in Table 3. The PNEC was estimated by dividing the lowest chronic NOEC<br />

by an assessment fac<strong>to</strong>r selected using European Union guidelines (ECHA, 2008b)<br />

and the RIFM Environmental Framework (Salvi<strong>to</strong> et al., 2002).<br />

2.2.3.1. Risk characterization. Potential risk <strong>to</strong> the aquatic environment <strong>for</strong> each<br />

subgroup was estimated from the ratio of the PEC <strong>to</strong> PNEC (PEC/PNEC) which


1624<br />

D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629<br />

Table 2<br />

Biodegradation summary.<br />

Material CAS# Method Test duration Results References<br />

(a) Ke<strong>to</strong>nes<br />

5-cyclohexadecen-1-one 37609-25-9 OECD 301B 28 days 81% and 83% RIFM (1996a)<br />

OECD 301C 26 days 52%, 60% and 68% RIFM (1997a)<br />

OECD 302C 28 days 60% RIFM (1997b)<br />

OECD 301F 28 days 86% RIFM (1997c)<br />

Cyclopentadecanone 502-72-7 OECD 302A 28 days 66.7% RIFM (1997d)<br />

4-cyclopentadecen-1-one, (Z)- 14595-54-1 OECD 301B 28 days 83.9% RIFM (1999a)<br />

OECD 302A 28 days 99.8% RIFM (1999b)<br />

3-Methylcyclopentadecenone 82356-51-2 OECD 301F 28 days 61% RIFM, 1996b<br />

OECD 301B 28 days 96.4% (10 mg/L) RIFM (1996c)<br />

93.4% (20 mg/L)<br />

OECD 301D 28 days 43% RIFM (1995a)<br />

SCAS 7 days 99.9% removal RIFM (1995b)<br />

OCED 301B 28 days 78.8% RIFM (2000a)<br />

OECD 302A 28 days 96.1% RIFM (2000b)<br />

OECD 302C 28 days 85% BOD; 100% GC RIFM (2000c)<br />

Cyclohexadecanone 2550-52-9 OECD 301B 28 days 43% RIFM, 2001a<br />

5-Cyclotetradecen-1-one, 3-methyl-<br />

259854-70-1 OECD 302C 28 days 75% RIFM (2004a)<br />

,(5E)<br />

OECD 301F 28 days 70% [73% after 34 days] RIFM (2004b)<br />

5-Cyclotetradecen-1-one, 3-methyl-<br />

,(5Z)<br />

259854-71-2 OECD 302C 28 days 75% RIFM, 2004a<br />

OECD 301F 28 days 70% [73% after 34 days] RIFM, 2004b<br />

3-Methyl-1-cyclopentadecanone 541-91-3 OECD 301F 28 days 80% RIFM (2009a)<br />

5-Cyclopentadecen-1-one, 3-methyl- 63314-79-4 OECD 301F 28 days 80% (100 mg/L); 81% (20 mg/L) RIFM (2009b)<br />

(b) Lac<strong>to</strong>nes/lactides<br />

Ethylene brassylate 105-95-3 ‘‘Closed Bottle’’ 28 days 40% RIFM (1996d)<br />

OECD 301F 28 days 73% RIFM (1996e)<br />

OECD 301F 28 days 77% RIFM (1996f)<br />

OECD 301F 28 days 89% RIFM (1998a)<br />

OECD 301B 28 days 78.1% RIFM (1994a)<br />

OECD 301F 28 days 83% RIFM (1999c)<br />

OECD 301C 28 days 85% BOD; 100% GC RIFM (1997e)<br />

OECD 301B 28 days 4100% RIFM (1997f)<br />

Ethylene dodecanedioate 54982-83-1 OECD 301B 28 days 80%; 78% RIFM (1997g)<br />

OECD 301C 28 days 73% BOD; 100% GC RIFM (1999d)<br />

OECD 301B 28 days 4100% RIFM (2000d)<br />

Oxacycloheptadec-10-ene-2-one 28645-51-4 OECD 301F 28 days 84% RIFM (1994b)<br />

Oxacycloheptadec-11-en-2-one 36508-31-3 OECD 301B 28 days 82% RIFM (1997h)<br />

10-Oxahexadecanolide 1725-01-5 OECD 301B 28 days 100% RIFM (1997i)<br />

11-Oxahexadecanolide 3391-83-1 OECD 301B 28 days 79.6% RIFM (1993)<br />

12-Oxahexadecanolide 6707-60-4 OECD 301B 28 days 96.5% RIFM (1996g)<br />

o-Pentadecalac<strong>to</strong>ne 106-02-5 OECD 301B 28 days 93% RIFM (1996h)<br />

OECD 301F 28 days 71% RIFM (2005)<br />

OECD 301B 28 days 82% RIFM (1998b)<br />

M.R Test C.4-D 28 days 90% RIFM (1996i)<br />

Oxacyclohexadecane-2,13-dione 38223-29-9 OECD 301B 28 days 83% (10 mg/L), 79% (20 mg/L) RIFM (1990a)<br />

E- and Z-Oxacyclohexadec-12(þ13)-<br />

111879-80-2 OECD 301F 28 days 95% RIFM (1996j)<br />

en-2-one<br />

OECD 301B 28 days 86.1% (10 mg/L); 87.1% (20 mg/L) RIFM (1995c)<br />

SCAS (SDA<br />

7 days Ave. removal: 95% RIFM (1995d)<br />

Method)<br />

OECD 301C 28 days 92% BOD; 100% GC RIFM, 1998c<br />

Oxacyclopentadec-10-en-2-one, 13-<br />

methyl<br />

Oxacyclopentadec-10-en-2-one, 13-<br />

methyl<br />

329925-33-9 OECD 111 120 h abiotic<br />

deg.<br />

(hydrolysis)<br />

0.4 mg/L<br />

329925-33-9 OECD 111 120 h abiotic<br />

deg.<br />

(hydrolysis)<br />

0.4 mg/L<br />

At pH values of 4 and 7 degradation is less than 10% after 5 days (equivalent <strong>to</strong> a<br />

half-life time higher than 1 year at 25 1C) and no more testing is required. For pH 9,<br />

about 50% degradation was observed after 120 h. In this case, a second degradation<br />

test was recommended at a lower temperature (35 1C)<br />

The low concentration measured at 120 h in the pH 7 solution is not in agreement<br />

with the results of the second preliminary test. An accidental loss during analysis<br />

may have occurred. The slow hydrolysis of the test material at pH 4 and 7, as<br />

observed at 50 1C is confirmed (half-life time higher than one year). Hydrolysis at<br />

pH 9 is slower than in the experiment at 50 1C, it also fits roughly a pseudo-first<br />

order law (straight line). From the two tests at 50 1C and 35 1C, a rate constant and<br />

half-life time at 25 1C can be calculated. The rate constant at 25 1C¼21.4 days<br />

RIFM (2000e)<br />

RIFM (2000e)<br />

OECD 301F 28 days 87%; 89% after 39 days RIFM (2000f)


D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629 1625<br />

Table 3<br />

Aquatic eco<strong>to</strong>xicity data.<br />

Material CAS# Method Test<br />

duration<br />

Species Results References<br />

(a) Ke<strong>to</strong>nes<br />

3- Methylcyclopentadecenone 82356-51-2 OECD 202 48 h Daphnia<br />

magna<br />

OECD 211 21 days Daphnia<br />

magna<br />

OECD 203 96 h Oncorhynchus<br />

mykiss<br />

OECD 201 72 h Scenedesmus<br />

subspicatus<br />

OECD 210: No<br />

dose response<br />

relationship—not<br />

used <strong>for</strong> RA: See<br />

Supplemental<br />

In<strong>for</strong>mation<br />

33 days Pimephales<br />

promelas<br />

Cyclohexadecanone 2550-52-9 OECD 202 48 h Daphnia<br />

magna<br />

5-Cyclotetradecen-1-one, 3-methyl-<br />

,(5E)<br />

5-Cyclotetradecen-1-one, 3-methyl-<br />

,(5Z)<br />

OECD 203: Conc<br />

based on initial<br />

conc; no material<br />

detected at study<br />

termination<br />

96 h Brachydanio<br />

rerio<br />

OECD 201 72 h Scenedesmus<br />

subspicatus<br />

259854-70-1 OECD 202 48 h Daphnia<br />

magna<br />

259854-71-2 OECD 202 48 h Daphnia<br />

magna<br />

5-Cyclopentadecen-1-one, 3-methyl- 63314-79-4 OECD 201 (ErC50<br />

was extrapolated<br />

<strong>to</strong> 754 mg/L;<br />

highest test conc.<br />

was 715 mg/L)<br />

OECD 211 (time<br />

weighted means)<br />

72 h Pseudokirchneriella<br />

subcapitata<br />

21 days Daphnia<br />

magna<br />

(b) Lac<strong>to</strong>nes/lactides<br />

Ethylene brassylate 105-95-3 OECD 202 48 h Daphnia<br />

magna<br />

OECD 203 96 h Brachydanio<br />

rerio<br />

OECD 202 21 day Daphnia<br />

magna<br />

67/548/EWT<br />

(Algae Inhibition<br />

Test)<br />

72 h Scenedesmus<br />

subspicatus<br />

Ethylene dodecanedioate 54982-83-1 OECD 202 48 h Daphnia<br />

magna<br />

OECD 203 96 h Oncorhynchus<br />

mykiss<br />

OECD 201 72 h Scenedesmus<br />

capricornutum<br />

EC50: 0.39 mg/L RIFM (1995e)<br />

NOEC: 0.18 mg/L<br />

EC50 (repro): 0.022 mg/L RIFM (2003a)<br />

LOEC: 0.045 mg/L: NOEC: 0.011 mg/L<br />

LC50: 0.45 mg/L RIFM (1995f)<br />

NOEC: 0.18 mg/L<br />

EbC50: 430 mg/L; ErC50: 430 mg/L; NOEC: Z30 mg/L RIFM (1995g)<br />

NOEC: 0.0020 mg/L (nominal) RIFM (2003b)<br />

0.00098 mg/L (mean measured)<br />

EC50:40.19 mg/L RIFM (2001b)<br />

LC50:40.1 mg/L RIFM (2001c)<br />

LC50: 40.22 mg/L<br />

EbC50: 41.8 mg/L; ErC50: 41.8 mg/L; NOEC: 41.8 mg/L RIFM (2001d)<br />

EC50: 0.58 mg/L RIFM (2004c)<br />

NOEC: 0.32 mg/L<br />

EC50: 0.58 mg/L RIFM (2004c)<br />

NOEC: 0.32 mg/L<br />

EbC50: 40.715 mg/L; RIFM (2009c)<br />

ErC50: 40.715 mg/L;<br />

NOEC: 0.371 mg/L<br />

EC50 (repro): 0.2534 mg/L RIFM (2009)<br />

LOEC: 0.1550 mg/L:<br />

NOEC: 0.0899 mg/L<br />

Geom. Mean EC0/EC100: 6.4 mg/L RIFM (1996k)<br />

Geom. Mean LC0/LC100: 1.23 mg/L RIFM (1996l)<br />

LOEC: 0.165 mg/L RIFM (1996m)<br />

NOEC: 0.088 mg/L<br />

EbC50: 5.2 mg/L; ErC50:46.9 mg/L; RIFM (1996n)<br />

NOEC: 3.48 mg/L<br />

EC50: 414 mg/L; NOEC: 14 mg/L RIFM (1997j)<br />

LC50: 0.88 mg/L; NOEC: 0.10 mg/L RIFM (1997k)<br />

EbC50: 1.9 mg/L; ErC50: 17 mg/L; RIFM (1997l)<br />

NOEC: 0.61 mg/L


1626<br />

D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629<br />

Table 3 (continued )<br />

Material CAS# Method Test<br />

duration<br />

Species Results References<br />

Oxacyclohepta dec-11-en-2-one 36508-31-3 OECD 202 48 h Daphnia<br />

magna<br />

o-Pentadeca lac<strong>to</strong>ne 106-02-5 (C.2), Directive<br />

67/548/EEC<br />

OECD 203 96 h Brachydanio<br />

rerio<br />

OECD 201 72 h Scenedesmus<br />

capricornutum<br />

(C.1) Directive 67/<br />

548/EEC<br />

48 h Daphnia<br />

magna<br />

96 h Brachydanio<br />

rerio<br />

OECD 202 21 days Daphnia<br />

magna<br />

(C.3), Directive<br />

67/548/EEC<br />

72 h Scenedesmus<br />

subspicatus<br />

Oxacyclohexa-decane-2,13-dione 38223-29-9 OECD 202 48 h Daphnia<br />

magna<br />

E- and Z-Oxacyclohexadec-12(þ13)-<br />

en-2-one<br />

E- and Z-Oxacyclohexa dec-12(þ13)-<br />

en-2-one<br />

Oxacyclopenta dec-10-en-2-one, 13-<br />

methyl<br />

OECD 202: 21 days Daphnia<br />

magna<br />

OECD 201 72 h Scenedesmus<br />

subspicatus<br />

OECD 203 96 h Cyprinus<br />

carpio<br />

111879-80-2 OECD 210 33 days Pimephales<br />

promelas<br />

111879-80-2 OECD 202 48 h Daphnia<br />

magna<br />

OECD 203 96 h Oncorhynchus<br />

mykiss<br />

OECD 202 21 days Daphnia<br />

magna<br />

OECD 201 72 h Scenedesmus<br />

subspicatus<br />

329925-33-9 OECD 202 48 h Daphnia<br />

magna<br />

OECD 203 96 h Cyprinus<br />

carpio<br />

OECD 201 72 h Selenastrum<br />

capricornutum<br />

EC50: 466 mg/l; RIFM (2000g)<br />

LC50: 42.5 mg/l; NOEC: 11.0 mg/l RIFM (2000h)<br />

EbC50 and ErC50:4113.5 mg/l; RIFM (1997m)<br />

EC0: 41.27 mg/L RIFM (1995h)<br />

LC0:40.11 mg/L RIFM (1994c)<br />

EC 0 / EC 100 (Immob; Geo Mean) 0.093 mg/L (0.28 mg/L (Nominal) RIFM,1996o<br />

EC 50 (Repro):40.068 mg/Lo0.127 mg/L [4 0.2 mg/Lo0.4 rng/l (Nominal)]<br />

NOEC (Repro) 0.068 rng/l [0.2 rng/l (Nominal)]<br />

LOEC (Repro): 0.127 rng/l [0.4 mg/L (Nominal)]<br />

NOEC: 0.26 mg/L: EbC50: 0.4 mg/L; ErC50: 40.47 mg/L RIFM (1996p)<br />

NOEC: 10 mg/L RIFM (1990b)<br />

EC50: 21.2 mg/L<br />

NOEC41.0 mg/L RIFM (1996q)<br />

EC50 41.0 mg/L<br />

EbC50: 11 mg/L; ErC50: 16 mg/L; RIFM (1994d)<br />

NOEC: 6.9 mg/L<br />

LC50: between 3.2 and 5.6 mg/L RIFM (1990e)<br />

NOEC: r1.8 mg/L<br />

NOEC: 0.027 mg/L (mean measured); 0.16 mg/L (nominal) RIFM ,(2003c)<br />

LOEC: 0.11 mg/L (mean measured); 0.50 mg/L (nominal)<br />

Nominal EC50: 0.88 mg/L RIFM (1995i)<br />

NOEC: 0.32 mg/L;<br />

Measured EC50: 0.48 mg/L<br />

NOEC: 0.24 mg/L<br />

Nominal LC50: 2.4 mg/L RIFM (1995j)<br />

NOEC: 1.0 mg/L;<br />

Measured LC50: 2.0 mg/L<br />

NOEC: 0.52 mg/L<br />

EC50 (immob): 0.27 mg/L, nominal; 0.079 mg/L, time-weighted mean measured<br />

EC50 (repro): 0.27 mg/L, nominal; 0.079 mg/L, time-weighted mean measured<br />

LOEC: 0.48 mg/L, nominal; 0.16 mg/L, time-weighted mean measured NOEC:<br />

0.15 mg/L, nominal; 0.039 mg/L, time-weighted mean measured<br />

RIFM (2002)<br />

EbC50: 2.4 mg/L; ErC50: 5.0 mg/L; NOEC: 0.625mg/L RIFM (1995k)<br />

EC50:40.686 mg/L RIFM (2001e)<br />

LC50: 40.884 mg/L RIFM (2001f)<br />

The NOEC corresponded with a WAF prepared at 10 mg/L <strong>for</strong> both cell growth<br />

inhibition and growth rate reduction. The NOEC exceeded the maximum solubility<br />

of 1.6 mg/L at 20 1C in distilled water and 0.6 mg/L at 20 1C and a pH of 7.0 in reconstituted<br />

medium<br />

RIFM (2001g)


D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629 1627<br />

Fig. 3. Decision process following categorization guidelines.<br />

defines the risk quotient. When the PEC/PNEC ratio is below one, the risk from the<br />

macrocyclic group is considered <strong>to</strong> be negligible at current volumes of use and<br />

thus no adverse aquatic impacts are expected. The screening-level risk assessment<br />

answers the question: ‘‘Is there a potential <strong>for</strong> ecological risk?’’. When the risk<br />

quotient exceeds one, a more robust assessment of the environmental risk is<br />

warranted <strong>to</strong> attempt <strong>to</strong> quantify the magnitude and probability of those risks.<br />

3. Results and discussion<br />

Read-across plays an important role in the risk assessment<br />

that follows. Following the guidance established in Section 1 of<br />

this paper, and having supported the hypothesis that these<br />

materials can be assessed as two groups of macrocyclic compounds,<br />

it is appropriate <strong>to</strong> read across from the data presented<br />

<strong>for</strong> both biodegradation and aquatic <strong>to</strong>xicity.<br />

3.1. Estimation of PECs—exposure assessment<br />

The annual volume of use range <strong>for</strong> the macrocyclic ke<strong>to</strong>nes in<br />

both Europe and North America is from o1 (low kg quantities) <strong>to</strong><br />

no greater than 50 metric <strong>to</strong>nnes in either region (resulting in the<br />

10–100 <strong>to</strong>nne <strong>to</strong>nnage band) and <strong>for</strong> macrocyclic lac<strong>to</strong>nes/lactides<br />

the volume of use range <strong>for</strong> both regions is o1 <strong>to</strong> no greater<br />

than 1000 metric <strong>to</strong>nnes in any one region; here, resulting in a<br />

41000 metric <strong>to</strong>nnes volume of use band (IFRA, 2008).<br />

Within the RIFM/FEMA Database there are 22 biodegradation<br />

studies available <strong>for</strong> 9 macrocyclic ke<strong>to</strong>nes and 28 studies <strong>for</strong> 11<br />

macrocyclic lac<strong>to</strong>nes/lactides (Table 2). Following OECD Guidelines<br />

(OECD, 2006b) <strong>for</strong> determining ready biodegradation (e.g.,<br />

considering the ‘‘10-day window’’), macrocyclic ke<strong>to</strong>nes range<br />

from inherent <strong>to</strong> readily biodegradable. However, the range of<br />

biodegradation (mineralization) from these studies ranges from a<br />

low of 43% <strong>to</strong> a high of 100%. In per<strong>for</strong>ming this assessment the<br />

quality of the data reported in the RIFM Database was evaluated.<br />

All studies followed OECD Guidelines. While data outliers are<br />

present, there was nothing present in the data reports <strong>to</strong> warrant<br />

their exclusion. There<strong>for</strong>e, all available biodegradation were used.<br />

The low values observed are not supported by the weight of<br />

evidence from the studies (see Table 2) evaluated <strong>for</strong> any<br />

individual compound but are included in this assessment <strong>for</strong><br />

completeness and <strong>to</strong> provide <strong>for</strong> a conservative evaluation of<br />

exposure. In applying the RIFM Framework, a conservative value<br />

of 1 h 1 is used as the biodegradation rate <strong>for</strong> these compounds.<br />

Macrocyclic lac<strong>to</strong>nes/lactides were largely found <strong>to</strong> be readily<br />

biodegradable with biodegradation ranging from 71% <strong>to</strong> 4100%<br />

in the available studies with a single outlier (40%) not supported<br />

by other studies <strong>for</strong> the same compound (ethylene brassylate). In<br />

applying the RIFM Framework, while a rate of 3 h 1 is acceptable,<br />

a conservative value of 1 h 1 was applied <strong>for</strong> biodegradation in<br />

the WWTP in the exposure assessment of these compounds.<br />

Based on these data, neither the macrocyclic ke<strong>to</strong>nes nor the<br />

macrocyclic lac<strong>to</strong>nes/lactides should be considered persistent in<br />

the aquatic environment.<br />

Based on these input parameters, and a 3:1 dilution ratio, the<br />

Framework estimates that the predicted concentration of macrocyclic<br />

ke<strong>to</strong>nes in river water within the mixing zone of the WWTP<br />

discharge would be range from o0.01 <strong>to</strong> 0.05 mg/L in Europe and<br />

from o0.01 <strong>to</strong> 0.03 mg/L in North America. For macrocyclic<br />

lac<strong>to</strong>nes/lactides, the concentration within the mixing zone<br />

would range from in Europe from o0.01 <strong>to</strong> 0.7 mg/L and from<br />

o0.01 <strong>to</strong> 1.0 mg/L in North America. These differences between<br />

regions occur because there are different input parameters <strong>for</strong> the


1628<br />

D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629<br />

model <strong>for</strong> Europe and North America (e.g., per capita water use)<br />

and <strong>to</strong>nnage varies between the two regions.<br />

3.2. Estimation of PNECs<br />

For 5 macrocyclics ke<strong>to</strong>nes, 3 algae inhibition studies, 4 daphnia<br />

immobilization studies, 2 fish acute lethality studies and 2 daphnia<br />

reproduction studies are available within the RIFM database. For<br />

7 macrocyclic lac<strong>to</strong>nes/lactides, 7 algae inhibition studies, 7 daphnia<br />

immobilization studies, 7 fish lethality studies, 4 daphnia<br />

reproduction studies and 1 fish early life stage study are available<br />

within the RIFM Database. For the ke<strong>to</strong>nes, and the lac<strong>to</strong>nes/<br />

lactides as well, eco<strong>to</strong>xicity studies are often difficult <strong>to</strong> per<strong>for</strong>m<br />

due <strong>to</strong> the poor solubility of the materials, their volatility, and<br />

their ability <strong>to</strong> degrade. Concerns about material solubility and the<br />

usefulness of the data do not negate the conservative nature of<br />

this assessment. In per<strong>for</strong>ming this assessment the quality of the<br />

data reported in the RIFM Database was evaluated. All studies<br />

followed OECD Guidelines. The chronic <strong>to</strong>xicity studies, run at<br />

lower concentrations below the water solubility, provide <strong>for</strong><br />

reliable data <strong>to</strong> be used in this group effects assessment. The acute<br />

data, while more prone <strong>to</strong> concerns about material solubility,<br />

appear <strong>to</strong> provide relatively consistent experimental values continuing<br />

<strong>to</strong> support the group effects assessment. In only one case, a<br />

Fish, Early Life Stage study of 3-methylcyclopentadecenone, was<br />

the data determined <strong>to</strong> be of sufficiently poor quality that it could<br />

not be used in this assessment (see Supplemental In<strong>for</strong>mation).<br />

These data are summarized in Table 3.<br />

For the macrocyclic ke<strong>to</strong>nes, the lowest acute EC 50 /LC 50 reported<br />

(algae, daphnia or fish) was 0.39 mg/L (D. magna immobilization<br />

study <strong>for</strong> 3-Methylcyclopentadecenone) and the lowest NOEC was<br />

0.011 mg/L (D. magna reproduction study <strong>for</strong> 3-Methylcyclopentadecenone).<br />

Two chronic endpoints are available (algae and daphnia),<br />

there<strong>for</strong>e an assessment fac<strong>to</strong>r of 50, as described in Salvi<strong>to</strong> et al.<br />

(2002) is applied <strong>to</strong> this NOEC. The PNEC derived <strong>for</strong> the macrocyclic<br />

ke<strong>to</strong>nesis0.22mg/L.<br />

For the macrocyclic lac<strong>to</strong>nes/lactides, the lowest acute EC 50 /LC 50<br />

reported (algae, daphnia or fish) was 0.0425 mg/L (Danio rerio<br />

lethality study <strong>for</strong> Oxacycloheptadec-11-en-2-one). This material<br />

is reported in other studies <strong>to</strong> be very poorly soluble (mean limit of<br />

solubility reported in its D. magna immobilization study is 66 mg/L).<br />

This may explain the difference observed in acute <strong>to</strong>xicity between<br />

this material and the other lac<strong>to</strong>nes/lactides where the next lowest<br />

acute endpoint reported is an order of magnitude higher (E b C 50 in<br />

an algae biomass based inhibition study <strong>for</strong> o-pentadecalac<strong>to</strong>ne).<br />

The lowest NOEC from a chronic <strong>to</strong>xicity study was 0.027 mg/L (fish<br />

early life stage study study <strong>for</strong> Oxacyclohexadecen-2-one). Three<br />

chronic endpoints are available (algae, daphnia, and fish), there<strong>for</strong>e<br />

an assessment fac<strong>to</strong>r of 10 is applied <strong>to</strong> this NOEC. The PNEC<br />

derived <strong>for</strong> the macrocyclic lac<strong>to</strong>nes/lactides is 2.7 mg/L.<br />

As with biodegradation, one rate applied <strong>to</strong> all chemicals<br />

within the subgroup, the PNEC is applied <strong>to</strong> all materials within<br />

each subgroup. Risk quotients are then calculated based on<br />

individual material PECs.<br />

3.3. Risk characterization<br />

The screening level risk quotient, PEC/PNEC ratio, <strong>for</strong> macrocyclic<br />

lac<strong>to</strong>nes/lactides ranges from o0.05 <strong>to</strong> 0.27 <strong>for</strong> the North<br />

American scenario and o0.05 <strong>to</strong> 0.35 <strong>for</strong> the European scenario<br />

identified in the RIFM Framework. The screening level PEC/PNEC<br />

ratio <strong>for</strong> macrocyclic ke<strong>to</strong>nes ranges from o0.05 <strong>to</strong> 0.14 <strong>for</strong> the<br />

North American scenario and o0.05 <strong>to</strong> 0.23 <strong>for</strong> the European<br />

scenario identified in the RIFM Framework (Figs. 4 and 5).<br />

Since the risk quotients <strong>for</strong> all materials are less than 1.0, the<br />

potential risks of macrocyclic fragrance ingredients <strong>to</strong> aquatic<br />

Fig. 4. Risk quotients <strong>for</strong> macrocyclic ke<strong>to</strong>nes categorized by volume bands<br />

(metric <strong>to</strong>nnes). Nine out of 15 materials are presented based on their EU <strong>to</strong>nnage<br />

and 9 out of 15 based on their US <strong>to</strong>nnage. Additional materials are not included as<br />

their risk quotients were <strong>to</strong>o low <strong>to</strong> be presented (50.01).<br />

Fig. 5. Risk quotients <strong>for</strong> macrocyclic lac<strong>to</strong>nes/lactides categorized by volume<br />

bands (metric <strong>to</strong>nnes). Seven out of 15 materials are presented based on their EU<br />

<strong>to</strong>nnage and 7 out of 15 based on their US <strong>to</strong>nnage. Additional materials are not<br />

included as their risk quotients were <strong>to</strong>o low <strong>to</strong> be presented (50.01).<br />

biota are negligible at current use levels. The RIFM Framework, as<br />

applied, has been designed <strong>to</strong> conservatively overpredict PEC/<br />

PNEC values. This screening-level assessment only evaluated the<br />

aqueous exposure pathway. It did not consider effects <strong>to</strong> sediment<br />

organisms or exposure via bioaccumulation in food.<br />

4. Conclusions<br />

The results of a screening-level aquatic ecological risk assessment<br />

using a group approach indicates that at the current volume<br />

of use, of macrocyclic fragrance materials do not pose a significant


D. Salvi<strong>to</strong> et al. / Eco<strong>to</strong>xicology and Environmental Safety 74 (2011) 1619–1629 1629<br />

risk <strong>to</strong> aquatic biota. This is primarily a function of the high<br />

degree of degradation expected in waste water treatment of<br />

macrocyclic fragrance materials resulting in efficient removal in<br />

wastewater treatment plants. Based on current volume of use, no<br />

PEC/PNEC ratio exceeds 1 <strong>for</strong> any material in any subgroup under<br />

any set of conditions identified in the RIFM Framework. The IFRA<br />

volume of use survey is revised every 4 years allowing RIFM <strong>to</strong><br />

reassess the aquatic risk of this class of fragrance materials.<br />

Acknowledgments<br />

The authors gratefully acknowledge the contributions<br />

Dr. Benjamin Parkhurst made <strong>to</strong> the development of this manuscript.<br />

The authors also acknowledge the <strong>Research</strong> <strong>Institute</strong> <strong>for</strong><br />

<strong>Fragrance</strong> <strong>Materials</strong> <strong>for</strong> their support of this project.<br />

Appendix A. Supplemental In<strong>for</strong>mation<br />

Supplementary data associated with this article can be found<br />

in the online version at doi:10.1016/j.ecoenv.2011.05.002.<br />

References<br />

Belsi<strong>to</strong>, D., Bickers, D., Bruze, M., Calow, P., Dagli, M., Fryer, A.D., Greim, H., Hanifin,<br />

J.H., Miyachi, Y., Saurat, J.H., Sipes, I.G., A <strong>to</strong>xicologic and derma<strong>to</strong>logic<br />

assessment of macrocylic ke<strong>to</strong>nes and derivatives when used as fragrance<br />

ingredients. Food and Chemical Toxicology, in press a.<br />

Belsi<strong>to</strong>, D., Bickers, D., Bruze, M., Calow, P., Dagli, M., Fryer, A.D., Greim, H., Hanifin,<br />

J.H., Miyachi, Y., Saurat, J.H., Sipes, I.G., A <strong>to</strong>xicologic and derma<strong>to</strong>logic<br />

assessment of macrocylic lac<strong>to</strong>nes and lactide derivatives when used as<br />

fragrance ingredients. Food and Chemical Toxicology, in press b.<br />

Bickers, D., Calow, P., Greim, H., Hanifin, J., Rogers, A., Saurat, J.H., Sipes, I., Smith,<br />

L., Tagami, H., 2003. The safety assessment of fragrance materials. Regula<strong>to</strong>ry<br />

Toxicology and Pharmacology 37 (2), 218–273.<br />

EMEA (European Medicine Agency), 2006. Guideline on the Environmental Risk<br />

Assessment of Medicinal Products <strong>for</strong> Human Use CHMP/SWP/4447/00. The<br />

European Agency <strong>for</strong> the Evaluation of Medicinal Products, London.<br />

ECHA (European Chemical Agency), 2008a. Guidance on In<strong>for</strong>mation Requirements<br />

and Chemical Safety Assessment Part E: Risk Characterization.<br />

European Chemicals Agency, Helsinki.<br />

ECHA (European Chemical Agency), 2008b. Guidance on In<strong>for</strong>mation Requirements<br />

and Chemical Safety Assessment Chapter R.10: Characterization of Dose<br />

[concentration]–response <strong>for</strong> Environment. European Chemicals Agency,<br />

Helsinki.<br />

Gao, J., Ellis, L., Wackett, L., 2010. The University of Minnesota Biocatalysis/<br />

Biodegradation Database: improving public access. Nucleic Acids <strong>Research</strong><br />

38, D488–D491.<br />

IFRA (International <strong>Fragrance</strong> Association), 2008. Volume of Use Survey.<br />

OECD (Organisation <strong>for</strong> Economic Cooperation and Development), 2005. Manual<br />

<strong>for</strong> investigation of HPV chemicals. Guidance on the Development and Use of<br />

Chemical Categories in the HPV Chemicals Programme (Chapter 3.2).<br />

OECD (Organisation <strong>for</strong> Economic Cooperation and Development), 2006a. OECD<br />

Guidelines <strong>for</strong> Testing of Chemicals, vol. 2. Section 2: Effects on Biotic Systems.<br />

Paris, France.<br />

OECD (Organisation <strong>for</strong> Economic Cooperation and Development), 2006b. OECD<br />

Guidelines <strong>for</strong> Testing of Chemicals, vol. 2. Section 3: Degradation and<br />

Accumulation. Paris, France.<br />

Salvi<strong>to</strong>, D., Senna, R., Federle, T., 2002. A framework <strong>for</strong> prioritizing fragrance<br />

materials <strong>for</strong> aquatic risk assessment. Environmental Toxicology and Chemistry<br />

21, 301–1308.<br />

Thomas, P., Holt, M., Lemaire, P., Malcomber, I., Salvi<strong>to</strong>, D., Thompson, R., 2008.<br />

A weight-of-evidence (woe) approach <strong>for</strong> determining mode of Action: an<br />

ECETOC case study. IEAM 4 (3), 374–375.<br />

Vaes, W.H.M., Urrestarazu-Ramos, E., Verhaar, H., Hermens, J.L.M., 1998. Acute<br />

<strong>to</strong>xicity of nonpolar versus polar narcosis: is there a difference? Environmental<br />

Toxicology and Chemistry 17, 1380–1384.<br />

Verhaar, H.J.M., De Jongh, J., Hermens, J.L.M., 1992. Modeling the bioconcentration<br />

of organic compounds by fish: a novel approach. Environmental Science &<br />

Technology 33 (22), 4069–4072.<br />

email: sciencereprints@elsevier.com<br />

TSP N78801

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!